SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000902664-24-001520
Filing Date
2024-02-14
Accepted
2024-02-14 06:04:17
Documents
1

Document Format Files

Seq Description Document Type Size
1 LEXEO THERAPEUTICS, INC. p24-0680sc13g.htm SC 13G 64395
  Complete submission text file 0000902664-24-001520.txt   65983
Mailing Address 9 WEST 57TH STREET 36TH FLOOR NEW YORK NY 10019
Business Address 9 WEST 57TH STREET 36TH FLOOR NEW YORK NY 10019 (212) 390-9100
D1 Capital Partners L.P. (Filed by) CIK: 0001747057 (see all company filings)

IRS No.: 822247965 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 345 PARK AVENUE SOUTH FLOOR 6 NEW YORK NY 10010
Business Address 345 PARK AVENUE SOUTH FLOOR 6 NEW YORK NY 10010 (212) 547-9879
Lexeo Therapeutics, Inc. (Subject) CIK: 0001907108 (see all company filings)

IRS No.: 854012572 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-94231 | Film No.: 24631844
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)